ATRASENTAN HYDROCHLORIDE
UNII E4G31X93ZA

Substance Identification & Data

This profile provides standardized clinical and technical data for Atrasentan Hydrochloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E4G31X93ZA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 195733-43-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

E4G31X93ZA

CAS Registry Number

195733-43-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ATRASENTAN HYDROCHLORIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

E4G31X93ZA

The specific atomic composition represented as a molecular structure string.

InChIKey

C29H38N2O6.ClH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

IJFUJIFSUKPWCZ-SQMFDTLJSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C1779

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

159595

Unique identification number in the NCBI database of chemical substances.

USAN ID

LL-05

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@H]1([C@H](CN([C@H]1c2ccc(cc2)OC)CC(N(CCCC)CCCC)=O)c3cc4OCOc4cc3)C(=O)O.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Atrasentan Hydrochloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ATRASENTAN HYDROCHLORIDE

Common Names & Synonyms

(2R,3R,4S)-1-((DIBUTYLCARBAMOYL)METHYL)-2-(P-METHOXYPHENYL)-4-(3,4-(METHYLENEDIOXY)PHENYL)-3-PYRROLIDINECARBOXYLIC ACID, MONOHYDROCHLORIDE

3-PYRROLIDINECARBOXYLIC ACID, 4-(1,3-BENZODIOXOL-5-YL)-1-(2-(DIBUTYLAMINO)-2-OXOETHYL)-2-(4-METHOXYPHENYL)-, MONOHYDROCHLORIDE, (2R-(2.ALPHA.,3.BETA.,4.ALPHA.))

ATRASENTAN HCL

ATRASENTAN HYDROCHLORIDE [MART.]

ATRASENTAN HYDROCHLORIDE [MI]

ATRASENTAN HYDROCHLORIDE [USAN]

ATRASENTAN HYDROCHLORIDE [WHO-DD]